Goldman Sachs Group set a CHF 320 target price on Roche Holding Ltd. Genussscheine (VTX:ROG) in a research report sent to investors on Wednesday morning, Borsen Zeitung reports. The brokerage currently has a buy rating on the healthcare company’s stock.
A number of other analysts also recently issued reports on ROG. Morgan Stanley reissued an equal weight rating and set a GBX 250 ($3.27) target price on shares of BT Group in a research report on Tuesday, April 30th. Credit Suisse Group set a €50.00 ($58.14) price objective on shares of Unilever and gave the company a neutral rating in a research report on Thursday, April 18th. UBS Group set a $160.00 price objective on shares of IBM and gave the company a buy rating in a research report on Wednesday, April 17th. Jefferies Financial Group increased their price objective on shares of IAC/InterActiveCorp from $260.00 to $270.00 and gave the company a buy rating in a research report on Thursday, April 18th. Finally, Barclays increased their price objective on shares of Intuit from $225.00 to $237.00 and gave the company an equal weight rating in a research report on Friday, May 24th. Three research analysts have rated the stock with a sell rating, four have issued a hold rating and ten have issued a buy rating to the company’s stock. Roche Holding Ltd. Genussscheine has an average rating of Hold and an average price target of CHF 280.19.
Roche Holding Ltd. Genussscheine has a 1 year low of CHF 214.30 and a 1 year high of CHF 273.
Rogers Corporation designs, develops, manufactures, and sells engineered materials and components worldwide. The company's Advanced Connectivity Solutions segment offers circuit materials and solutions for connectivity applications in wireless communications infrastructure, automotive, connected devices, wired infrastructure, consumer electronics, and aerospace/defense.
Featured Article: How can investors find ex-dividend dates?
Receive News & Ratings for Roche Holding Ltd. Genussscheine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. Genussscheine and related companies with MarketBeat.com's FREE daily email newsletter.